Zobrazeno 1 - 10
of 1 955
pro vyhledávání: '"A T Cohen"'
Autor:
Daniël Duijzer, Maria A. de Winter, Marc Carrier, Alexander T. Cohen, John-Bjarne Hansen, Karin A.H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Henrik T. Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A.N. Dorresteijn, Mathilde Nijkeuter
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102569- (2024)
Background: After 3 months of anticoagulation for venous thromboembolism (VTE), the decision needs to be made whether to stop anticoagulation or extend treatment indefinitely. The VTE-PREDICT calculator can be used to estimate individual risks of VTE
Externí odkaz:
https://doaj.org/article/762594d3a38a49cfa6a9cbbcee03a280
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160064 (2016)
Historically, warfarin or aspirin have been the recommended therapeutic options for the extended treatment (>3 months) of VTE. Data from Phase III randomised controlled trials (RCTs) are now available for non-VKA oral anticoagulants (NOACs) in this i
Externí odkaz:
https://doaj.org/article/35d7317932fa416bb51ce4eb22b69693
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163386 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0160064.].
Externí odkaz:
https://doaj.org/article/3d216d9cb60946259394f3985eba0cab
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144856 (2015)
BACKGROUND:Anticoagulation with low molecular weight heparin and vitamin K antagonists is the current standard of care (SOC) for venous thromboembolism (VTE) treatment and prevention. Although novel oral anti-coagulants (NOACs) have been compared wit
Externí odkaz:
https://doaj.org/article/b8b44e73dab04dd391fc3f63f42434b5
Autor:
Daichi Shimbo, Morgan T. Cohen, Matthew McGoldrick, Ipek Ensari, Keith M. Diaz, Jie Fu, Andrea T. Duran, Shuqing Zhao, Jerry M. Suls, Matthew M. Burg, William F. Chaplin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Provoked anger is associated with an increased risk of cardiovascular disease events. The underlying mechanism linking provoked anger as well as other core negative emotions including anxiety and sadness to cardiovascular disease remain un
Externí odkaz:
https://doaj.org/article/a465f6e9f13d45f1857c0568a9fc0920
Autor:
Kevin G. Pollock, Carissa Dickerson, Manjit Kainth, Sarah Lawton, Michael Hurst, Daniel M. Sugrue, Chris Arden, D. Wyn Davies, Anne-Céline Martin, Belinda Sandler, Jason Gordon, Usman Farooqui, David Clifton, Christian Mallen, Jennifer Rogers, Nathan R. Hill, A. John Camm, Alexander T. Cohen
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Conducting effective and translational research can be challenging and few trials undertake formal reflection exercises and disseminate learnings from them. Following completion of our multicentre randomised controlled trial, whic
Externí odkaz:
https://doaj.org/article/27c52a2dc0a040fbb3abfb3cdcb472c8
Autor:
Nathan T. Cohen, Phat Chang, Taha Gholipour, Chima Oluigbo, L. Gilbert Vezina, Hua Xie, Anqing Zhang, William D. Gaillard
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 11, Pp 2161-2165 (2023)
Abstract To evaluate the role of focal cortical dysplasia co‐localization to cortical functional networks in the development of pharmacoresistance. One hundred thirty‐six focal cortical dysplasia patients with 3.0 T or 1.5 T MRI were identified f
Externí odkaz:
https://doaj.org/article/30b9da490ad244959a3413b95a04cb8e
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 116-116 (2024)
OBJECTIVES/GOALS: Many economic evaluations rely on clinical trial data that may not represent real world populations and intervention effectiveness. We compare risk and cost-effectiveness for the Diabetes Prevention Program (DPP) clinical trial coho
Externí odkaz:
https://doaj.org/article/62028311ae274fb695b7351325404da5
Autor:
Gregory J. Fermann, Brooks D. Cash, Nayantara Coelho‐Prabhu, Marc Maegele, Roland Bingisser, Vinay Sehgal, Alexander T. Cohen, Anna Hundt Golden, Jon Russo, Mark Price, Allen Mangel, Bruce Koch, Mary J. Christoph, Truman J. Milling Jr.
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 4, Iss 5, Pp n/a-n/a (2023)
Abstract Objective To define and contextualize life‐threatening gastrointestinal (GI) bleeding in the setting of factor Xa (FXa) inhibitor therapy and to derive a consensus‐based, clinically oriented approach to the administration of FXa inhibito
Externí odkaz:
https://doaj.org/article/1270a691872e4c78bfdff0c178ab6aa6
Autor:
Kimberly Snow Caroti PharmD, Alok A. Khorana MD, Cecilia Becattini MD, Agnes Y.Y. Lee MD, Anders Ekbom MD, Marc Carrier MD, Alexander T. Cohen MD, Christopher Brescia BS, Khaled Abdelgawwad MSc, MBA, George Psaroudakis PhD, Marcela Rivera PhD, Bernhard Schaefer BS, Gunnar Brobert PhD, Craig I. Coleman PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Cancer-associated venous thromboembolism (CAT) guidelines recommend direct oral anticoagulants as alternatives to low-molecular-weight heparin (LMWH) in most patients. This study compared the effectiveness and safety of rivaroxaban versus LMWH for a
Externí odkaz:
https://doaj.org/article/d9a5ff0f4ce140bdb2925b75475697e0